Remove COVID-19 Remove Hospital Remove Myocardial Infarction
article thumbnail

Prevalence and effects of acute myocardial infarction on hospital outcomes among COVID-19 patients

Coronary Artery Disease Journal

Background Acute myocardial infarction (AMI) is one of the most lethal complications of COVID-19 hospitalization. In this study, we looked for the occurrence of AMI and its effects on hospital outcomes among COVID-19 patients. Prolonged LOS was defined as any hospital LOS ≥ 75th percentile.

article thumbnail

The impact of COVID-19 and the COVID-19 pandemic on hospitalized patients with STEMI in the United States: insights from the National Inpatient Sample

Coronary Artery Disease Journal

Background It is unclear how COVID-19 pandemic affected care and outcomes among patients who are diagnosed with ST-elevation myocardial infarction (STEMI) in the USA. Results There were 1 050 905 hospitalizations with STEMI, and there was an 8.2% 12.55, P < 0.001) with COVID-19 infection compared with no infection.

article thumbnail

Impact of the COVID-19 pandemic on acute coronary syndrome hospital admission and management in Slovenia

Open Heart

Aims We evaluated the effects of the COVID-19 pandemic on hospital admission and quality of care for acute coronary syndrome. Data on 21 001 patients were included (7057 ST-elevation myocardial infarction (STEMI), 7649 non-ST elevation myocardial infarction (NSTEMI) and 6295 unstable angina).

article thumbnail

Impact of COVID-19 on Digital Cardiology Care

SoftCath

Since the onset of COVID-19, cardiology care has been under extreme risk and adverse complications. For this reason, the management of cardiac patients in the hospital environment has proven to be a real, enormous challenge during and after the pandemic.

article thumbnail

Classification Algorithm to Distinguish Between Type 1 and Type 2 Myocardial Infarction in Administrative Claims Data

Circulation: Cardiovascular Quality & Outcomes

Background:Type 2 myocardial infarction (T2MI) and type 1 myocardial infarction (T1MI) differ with respect to demographics, comorbidities, treatments, and clinical outcomes. 3.48]), and diagnoses of COVID-19 (odds ratio, 1.74 [95% CI, 1.11–2.71]) T1MI and 53.5% T2MI; mean age, 79±10.3 years; 47% female).

article thumbnail

Rationale and Design for the LOnger-term effects of SARS-CoV-2 INfection on blood Vessels And blood pRessure (LOCHINVAR): an observational phenotyping study

Open Heart

Introduction COVID-19 may lead to long-term endothelial consequences including hypertension, stroke and myocardial infarction. mm Hg higher BP ≥12 weeks after recovery, compared with a group without COVID-19. mm Hg higher BP ≥12 weeks after recovery, compared with a group without COVID-19.

article thumbnail

Very early invasive strategy in higher risk non-ST-elevation acute coronary syndrome: the RAPID NSTEMI trial

Heart BMJ

The primary outcome was a composite of all-cause mortality, new myocardial infarction or hospitalisation for heart failure at 12 months. Results The trial was discontinued early by the funder due to slow recruitment during the COVID-19 pandemic. The length of hospital stay was reduced with a very early IS (3.9